Influenza :: Acambis’ universal influenza vaccine enters Phase 1 trial
Acambis plc (Acambis) (LSE: ACM), a leading vaccines company, announces that it has initiated a Phase 1 clinical trial of its universal influenza vaccine candidate, ACAM-FLU-A.
Acambis plc (Acambis) (LSE: ACM), a leading vaccines company, announces that it has initiated a Phase 1 clinical trial of its universal influenza vaccine candidate, ACAM-FLU-A.
Every year, thousands of parents learn of their children’s food allergies following a reaction that can affect many body systems, including the respiratory system, the gastrointestinal tract, skin or cardiovascular system.
A universal influenza vaccine that has been pioneered by researchers from VIB and Ghent University is being tested for the first time on humans by the British-American biotech company Acambis.
Researchers isolated bisdemethoxycurcumin, the active ingredient of curcuminoids ? a natural substance found in turmeric root ? that may help boost the immune system in clearing amyloid beta, a peptide that forms the plaques found in Alzheimer’s disease.
It has long been known that type 1 diabetes is an autoimmune disease. The body attacks the islet cells in the pancreas that produce insulin.
Researchers at the University of Pennsylvania School of Medicine identified a combination therapy as a way to sensitize resistant human cancer cells to a treatment currently being tested in clinical trials.
A diagnosis of type I diabetes means a life sentence of medical follow-up. While treatments have become simpler and less restrictive in recent years, they are still a burden, especially for young patients.
With HIV infection driving a deadly resurgence of tuberculosis (TB), a new publication provides up-to-date recommendations for clinicians facing the many challenges of treating patients with both of these two complex diseases.
Pediatrics researchers at The Children?s Hospital of Philadelphia and McGill University in Montreal have identified a gene variant that raises a child?s risk for type 1 diabetes, formerly called juvenile diabetes.
The incidence of serious strep infections has risen dramatically in the last three decades, and this increase is largely attributed to the spread around the globe of a single strain of strep known as the invasive M1T1 clone.